Amantadine Solution
Product Images NDC 0116-4010

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Amantadine (NDC 0116-4010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xttrium Laboratories, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amantadine 16oz Label 1 (Amantadine 16oz 1)

This label text panel details Amantadine Hydrochloride Oral Solution, USP 50 mg/5 mL by Xttrium Laboratories, Inc. It includes the chemical structure of amantadine hydrochloride, a description of the product, clinical pharmacology, mechanism of action for antiviral and Parkinson's disease uses, and pharmacokinetics information including absorption, metabolism, and excretion.*

FDA Label Image

Amantadine 16oz Label 2 (Amantadine 16oz 2)

The image shows a text panel titled 'INDICATIONS AND USAGE' for Amantadine Hydrochloride Oral Solution 50 mg/5 mL by Xttrium Laboratories. It details indications for influenza A prophylaxis and treatment, Parkinson's disease treatment, and drug-induced extrapyramidal reactions. The panel includes contraindications, warnings such as overdose risks, CNS effects, precautions on abrupt discontinuation, and patient guidance.*

FDA Label Image

Amantadine 16oz Label 3 (Amantadine 16oz 3)

This image displays a detailed drug information text panel for Amantadine oral solution. It includes warnings and clinical considerations such as Neuroleptic Malignant Syndrome, renal and liver disease precautions, impulse control disorders, melanoma risk, and other medical advice relevant to patients and healthcare providers.*

FDA Label Image

Amantadine 16oz Label 4 (Amantadine 16oz 4)

Text panel titled "Drug Interactions" for Amantadine oral solution detailing interactions with other drugs, effects on fertility, pregnancy risks including teratogenic effects, nursing mother considerations, pediatric use, and usage guidelines for elderly patients. It provides specific warnings and summaries of scientific studies related to these topics.*

FDA Label Image

Amantadine 16oz Label 5 (Amantadine 16oz 5)

This drug facts panel lists adverse reactions and overdose information for Amantadine hydrochloride oral solution. It details common to rare side effects affecting various systems including nervous, cardiovascular, respiratory, gastrointestinal, hematologic, sensory, skin, and miscellaneous reactions. Overdose symptoms and recommended support measures are also described, emphasizing monitoring and management of toxic effects.*

FDA Label Image

Amantadine 16oz 6 Label (Amantadine 16oz 6)

This text panel provides dosage and administration details for Amantadine Hydrochloride Oral Solution 50 mg/5 mL by Xttrium Laboratories, Inc. It includes dosing instructions for various conditions such as influenza A virus illness, Parkinsonism, drug-induced extrapyramidal reactions, and impaired renal function. The panel also covers storage conditions, supply information, and manufacturer details.*

FDA Label Image

Amantadine 16oz Front (Amantadine 16oz Comp.)

Label for Amantadine Hydrochloride oral solution, USP 50 mg/5 mL by Xttrium Laboratories, Inc. The label includes dosage strength, manufacturer details, storage instructions, and a warning to keep out of reach of children. The packaging is for a 1 pint (473 mL) bottle with a tamper-evident seal caution.*

FDA Label Image

Amantadine 5-6 (Amantadine Back 5 6)

This image shows a multi-column text panel of prescribing information for Amantadine hydrochloride oral solution. It covers safety warnings, drug interactions, precautions, pregnancy and nursing considerations, adverse reactions, drug overdose details, and guidance for patients and healthcare providers. The text is densely packed and formatted as a typical drug label information insert.*

FDA Label Image

Amantadine 7-8 (Amantadine Back 7 8)

This image shows the Drug Facts and detailed prescribing information for Amantadine Hydrochloride oral solution, including dosage and administration guidelines, dosage adjustments for renal impairment, dosing for prophylaxis and treatment of influenza A virus illness, Parkinsonism dosage, pharmacological precautions, side effects, and storage instructions. It also provides references and manufacturer information for Xttrium Laboratories, Inc.*

FDA Label Image

Amantadine Table (Amantadine Chart)

A dosing guideline panel for Amantadine Hydrochloride listing dosage recommendations according to creatinine clearance levels (mL/min/1.73m²). Dosages for clearance ranges 30 to 50, 15 to 29, and less than 15 are specified, including initial and maintenance doses and alternate-day dosing schedules.*

FDA Label Image

Amantadine 1-2 (Amantadine Front 1 2)

This text panel is the prescribing information for Amantadine Hydrochloride Oral Solution USP 50 mg/5 mL by Xttrium Laboratories, Inc. It includes a chemical structure diagram of amantadine hydrochloride, description of its physical and chemical properties, pharmacodynamics, antiviral and Parkinson's disease mechanisms, drug resistance, and pharmacokinetics data. The detailed information covers absorption, metabolism, dosage effects, and clinical study insights.*

FDA Label Image

Amantadine 3-4 (Amantadine Front 3 4)

This image shows the labeled drug information panel for Amantadine Hydrochloride Oral Solution, USP. It includes sections on indications, usage, contraindications, warnings, precautions, and detailed clinical pharmacology related to Amantadine hydrochloride. The text covers safety considerations such as overdose, suicide risk, CNS effects, and special populations like patients with renal or liver issues.*

FDA Label Image

Amantadine Mc (Amantadine Molecule)

Chemical structure of amantadine hydrochloride showing the bicyclic amine structure with the molecular formula C10H17N·HCl and molecular weight 187.71.*

FDA Label Image

Amantadine 10ml Lid (Amantadine Ud 10ml)

Amantadine Hydrochloride Oral Solution USP, 100 mg per 10 mL, unit dose packaging delivering 10 mL. The label includes the NDC number 0116-4010-10 and specifies Rx use only. Manufactured by Xttrium Laboratories, Inc., Mount Prospect, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.